CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the first ...
A late-breaking study presented at the PERT Consortium 2025 Pulmonary Embolism Scientific Symposium in San Diego showed marked clot-burden reduction with no device-related serious adverse events for ...
Listening to patients is no longer a “nice to have” for life sciences companies—it is a strategic necessity that can ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. New investors HealthCor Investments LLC ...